Capital Fund Management (CFM)’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-324
Closed -$534K 1669
2019
Q2
$534K Sell
324
-131
-29% -$227K ﹤0.01% 1197
2019
Q1
$928K Buy
455
+193
+74% +$340K 0.01% 1056
2018
Q4
$337K Sell
262
-147
-36% -$225K ﹤0.01% 1555
2018
Q3
$774K Buy
409
+224
+121% +$463K ﹤0.01% 1457
2018
Q2
$377K Sell
185
-795
-81% -$1.81M ﹤0.01% 1709
2018
Q1
$2.17M Buy
980
+231
+31% +$588K 0.01% 989
2017
Q4
$1.73M Buy
+749
New +$1.52M 0.01% 1040
2017
Q3
Sell
-224
Closed -$305K 1524
2017
Q2
$305K Buy
+224
New +$270K ﹤0.01% 1265
2017
Q1
Sell
-409
Closed -$327K 1470
2016
Q4
$327K Buy
409
+85
+26% +$67.5K ﹤0.01% 1416
2016
Q3
$285K Buy
+324
New +$235K ﹤0.01% 1394
2016
Q2
Sell
-463
Closed -$255K 1531
2016
Q1
$255K Sell
463
-155
-25% -$95.2K ﹤0.01% 1371
2015
Q4
$514K Buy
+618
New +$617K 0.01% 1114
2015
Q3
Sell
-340
Closed -$741K 1418
2015
Q2
$741K Buy
+340
New +$693K 0.01% 920

Other funds holding BLUE

Capital Fund Management (CFM)'s BLUE Position: Q2 2022 in Review

Capital Fund Management (CFM) sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 12,908 shares — an estimated $1.25M sold.

Capital Fund Management (CFM) first reported a position in BLUE in Q2 2015 and held it in 14 quarters. The position peaked at $16.6M in Q4 2015. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Capital Fund Management (CFM) reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 12,908 bluebird bio shares in Q2 2022, an estimated $1.25M.
  • Capital Fund Management (CFM) first reported a position in bluebird bio in Q2 2015 and held it in 14 quarters.
  • Capital Fund Management (CFM)'s bluebird bio position peaked at $16.6M in Q4 2015.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2022, filed 12 Aug 2022.